Recruiting PHASE3 INTERVENTIONAL 2-arm NCT06698666

Efficacy of Statins Among Major Depressive Disorder

The Efficacy of Statins in Management of Major Depression Disorder (MDD) Among Adult Patients Attending the Outpatient Clinics of El Demerdash Hospital.

Sponsor: Ain Shams University

Conditions MDD Major Depressive Disorder

Interventions Rosuvastatin 10 mg tablet. Sertraline Pill

Updated 3 times since 2024 Last updated: Aug 14, 2025 Started: Oct 1, 2022 Primary completion: Dec 4, 2024 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06698666, this PHASE3 trial focuses on MDD and Major Depressive Disorder and remains actively recruiting participants. Sponsored by Ain Shams University, it has been updated 3 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Oct 2025 — Present [monthly]

Recruiting PHASE3
Sep 2025 — Oct 2025 [monthly]

Recruiting PHASE3
Dec 2024 — Sep 2025 [monthly]

Recruiting PHASE3

First recorded

Oct 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ain Shams University

Data source: Ain Shams University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt